Myosin heavy chain messenger RNA from myogenic cell cultures

The regulation of protein synthesis in heart muscle under normal conditions and in the adriamycin-cardiomyopathy

The regulation of cardiac protein synthesis, in particular messenger-RNA (mRNA) and polyribosome metabolism, has been investigated in normal rat heart muscle and in the adriamycin-cardiomyopathy by using newly developed methods for the isolation, characterization and in-vitro translation of cardiac polyribosomes and mRNA. The obtained data allow the following conclusions: 1. Normal heart muscle has a high content of polyribosomes (865 micrograms/g) and of mRNA (20-60 micrograms/g), and thus a high rate of protein synthesis. 2. The level of cardiac polyribosomes and mRNA is strictly age-dependent and much higher in young animals (2-3 x). This corresponds to a higher cardiac protein synthesis rate in young animals with a growing heart muscle, and shows that the protein-synthetic reserves of heart muscle decrease sharply with age. 3. Withdrawal of food for 1-3 days results in a pronounced decrease (-50% to -70%) of cardiac polyribosomes and mRNA, demonstrating that the cardiac protein synthesis reacts very sensitively to conditions of starving. 4. The cardiac polyribosomes and mRNA are unevenly distributed in the myocyte. The bulk of these substances is present in the cardiac microsomes, and much less is found in nuclei, myofibrils, mitochondria and in the post-microsomal fraction (=cell-sap) of the cardiac muscle. This shows that the major intracellular site of cardiac protein synthesis is the microsomal fraction of the myocyte. 5. A pool of untranslated mRNA was demonstrated to be present in the cell-sap of the myocyte. This mRNA is to some extent translatable in-vitro and appears to represent mRNA sub-pools with two functions: a) mRNA which is partially broken down or in the process of being broken down, and b) intact mRNA which could have a "reserve-function", e.g., by being utilized to increase cardiac protein synthesis under certain conditions. 6. A method of quantitating small amounts of cardiac mRNA (25-50 ng) has been developed which makes it possible to estimate the mRNA content of cardiac biopsies. 7. These methods were utilized to study the relevance of changes in RNA- and protein synthesis in the development of the adriamycin-cardiomyopathy. It appears that severe decreases in cardiac mRNA and polyribosome levels are a key factor in the pathogenesis of the adriamycin-cardiomyopathy. These decreases are probably caused by the direct binding of adriamycin to cardiac DNA and lead themselves to a persisting decrease in cardiac protein synthesis which in view of the short half-lives of the cardiac contractile proteins (5-12 days) causes a gradual loss of cardiac structure and function.

Metabolism of poly (A)-containing mRNA in myocardium under normal physiological conditions and compensatory cardiac hyperfunction

Two fractions of mRNA poly A+ and poly A- mRNA have been found in rat heart muscle by the method of affinity chromatography. These fractions amount to 30 and 70% of the total RNA respectively. The relationship between poly A+ and poly A-mRNA in myocardium does not alter in heart hyperfunction and aging. The life-span of mRNA reduces to 2-3 hours in the beginning of the process of myocardium hyperfunction development; the lifespan of mRNA does not differ from the controls in prolonged heart hyperfunction (6 months). The rate of poly A+mRNA synthesis increases by 70% compared to controls in the early stage of heart hyperfunction; it falls below the control level in long-term hypertrophied myocardium. This decreases in the rate of mRNA transcription in compensatory heart hypertrophy can play an important role in wear of the organ and in premature development of aging changes in the heart.

[The regulation of protein synthesis in heart muscle. Biochemical data, stimulative and inhibitory factors and their clinical significance (author's transl)]

The regulation of protein synthesis in heart muscle has been investigated by many authors under both normal and pathological conditions. This review summarizes the evidence for the dependence of normal heart protein synthesis from normal serum levels of insulin, amino acids, fatty acids and glucose. A decreased serum concentration of these substances causes an inhibition of heart muscle protein synthesis by 30--60%. Various drugs and other chemical lead to similar impairments of heat muscle protein synthesis. The resulting imbalance between synthesis and degradation of myocardial proteins with their half-times of 5--12 days gradually leads to a decrease in their myocellular concentration with a consequent impairment of myocardial function. Finally, the biochemial sequences are described which represent the important pathogenetic mechanisms in the development of heart muscle hypertrophy and in the adriamycin-induced cardiomyopathy.

Most myosin heavy chain mRNA in L6E9 rat myotubes has a short poly(A) tail

The mRNA for rat muscle myosin heavy chain (MHC) was isolated from L6E9 myotubes by two rounds of sucrose density gradient centrifugation followed by fractionation on an agarose/polyacrylamide gel. The purity of the mRNA isolated was determined by translation in vitro, peptide analysis of the in vitro product and comparison with authentic MHC, analysis of the kinetics of hybridization with cDNA prepared with this RNA, and titration analysis of total cytoplasmic RNA from muscle and nonmuscle sources. By using the MHC cDNA as probe of myogenic differentiation, it was observed that the level of cytoplasmic MHC mRNA increased approximately 200-fold as the dividing myoblast differentiated into the fused myotube. Titration analysis of RNAs fractionated by oligo(dT)-cellulose chromatography indicated that the majority of the increase occurred in that RNA population that failed to bind to an oligo(dT)-cellulose column.

Sub-cellular distribution of the cytoplasmic myosin heavy chain mRNA during myogenesis

In the light of earlier work [1] which demonstrated the presence of a large number of myosin heavy chain (MHC) transcripts in chick myoblasts prior to cell fusion and the burst of MHC synthesis it was of great interest to determine the subcellular localization of the still inactive transcripts. It has been determined in differentiating muscle cells in culture. Two populations of cells were examined -- monucleated myoblasts just prior to cell fusion and myotubes where at least 80% of the cells were fused. Utilizing a myosin complementary DNA (cDNA) probe [2] it is observed that just prior to cell fusion, when the "burst" of myosin synthesis has not yet occurred, the vast majority of cytoplasmic myosin mRNA transcripts are found in a stored messenger RNA protein complex with a minimal amount found in the heavy polysome fraction. In differentiated myotube cultures, when myosin synthesis is progressing at a high rate, the reverse is found, i.e, the amount of stored myosin messenger RNA (mRNA) is minimal while the largest amount of myosin mRNA transcripts are localized in the polysome fraction. The number of total cytoplasmic myosin transcripts is found to decrease after cell fusion at a time when myosin synthesis is maximal suggesting that the efficiency of translation of myosin mRNA increases during terminal differentiation.

Translation of mRNA for glutamate dehydrogenase and spectrophotometric procedure to follow the enzyme biosynthesis

Heterogeneous poly (A)-mRNA fraction was isolated from rat liver microsomes using phenol-chloroform extraction, millipore filtration and poly (U)-agarose affinity chromatography. Obtained fractions were characterized with respect to their secondary structure and poly (A) content. Isolated poly (A)-mRNA fraction contained high template activity for glutamate dehydrogenase in cell-free systems with microsomes or polysomes. A spectrophotometric procedure to follow enzyme biosynthesis was also developed.

Calcium-related changes of enzyme activities in energy metabolism of cultured embryonic chick myoblasts and myotubes

Changes in activity of enzymes involved in energy metabolism have been determined in unfused, fused as well as in fusion-inhibited chick embryo muscle cells in vitro. Functionally related enzymes which supposedly are coded by "gene clusters" show a similar degree and rate of enzyme activity increase. Hexokinase and glucose-6-phosphate dehydrogenase reveal only slight activity changes during muscle cell development under the conditions studied. The elevation of phosphofructokinase can be distinguished from that of the other glycolytic enzymes by its higher rate of increase and from that of phosphorylase by its time-course of activity change. The Ca2+ dependence of the phosphorylase activity increase runs parallel to myoblast fusion rate. Experiments in which calcium was removed from cultures which had reached the final morphological state of mature myotubes 24 h after onset of fusion show that increases of enzyme activities are irreversible and that these increases proceed at unchanged rates. Experimental evidence suggest that although fusion and enzyme syntheses may be uncoupled, both are similarly triggered by being dependent on Ca2+ concentration.

Synthesis of myosin heavy and light chains in muscle cultures

The weight ratio of myosin/actin, the myosin heavy chain content as the percentage of total protein (wt/wt), and the kinds of myosin light chains were determined in (a) standard muscle cultures, (b) pure myotube cultures, and (c) fibroblast cultures. Cells for these cultures were obtained from the breast of 11-day chick embryos. Standard cultures contain, in addition to myotubes, large numbers of replicating mononucleated cells. By killing these replicating cells with cytosine arabinoside, pure myotube cultures were obtained. The myosin/actin ratio (wt/wt) for pure myotube, standard muscle, and fibroblast cultures average 3.1, 1.9, and 1.1 respectively. By day 7, myosin in myotube cultures represents a minimum of 7% of the total protein, but about 3% in standard cultures and less than 1.5% in fibroblasts cultures. Myosin from standard cultures contains light chain LC1, LC2, and LC3, with a relative stoichiometry of the molarity of 1.0:1.9:0.5 and mol wt of 25,000, 18,000 and 16,000 daltons, identical to those in adult fast muscle. Myosin from pure myotubes exhibits light chains LC1 and LC2, with a molar ratio of 1.5:1.6. Myosin from fibroblast cultures possesses two light chains with a stoichiometry of 1.8:1.8 and mol wt of 20,000 and 16,000 daltons. Clearly, the faster migrating light chain, LC3, found in standard cultures is synthesized not by the myotubes but ty the mononucleated cells. In myotubes, both the assembly of the sarcomeres and the interaction between thick and thin filaments required for spontaneous contraction occur in the absence of light chain LC3. One set of structural genes for the myosin light and heavy chains appears to be active in mononucleated cells, whereas another set appears to be active in multinucleated myotubes.

Differences among myosins synthesized in non-myogenic cells, presumptive myoblasts, and myoblasts

Myosins synthesized in non-myogenic cells and replicating presumptive myoblasts differ from those synthesized in postmitotic mononucleated myoblasts and myotubes. Myoblasts and myotubes synthesize the definitive light chains, MLC1 and MLC2. These light chains display different molecular weights in sodium dodecyl sulfate-polyacrylamide gels from the fibroblast light chains FLC1 and FLC2 synthesized in non-myogenic cells and presumptive myoblasts. There are immunological differences between the myosin heavy chains synthesized in myoblasts and myotubes and those synthesized in non-myogenic cells and presumptive myoblasts. Fluorescein-labeled antibodies against skeletal light meromyosin are bound only along the lateral edges of emerging and definitive A-bands. This antibody to light meromyosin is not bound to the outside of, or the microfilaments subtending, the plasma membrane in non-myogenic cells or in myoblasts or in myotubes. These findings suggest that: (1) non-myogenic cells and replicating presumptive myoblasts synthesize similar myosin heavy and light chains; (2) replicating presumptive myoblasts synthesize a different set of myosins from those synthesized by their postmitotic daughters, the myoblasts; (3) the myosins associated with the plasma membranes of non-myogenic and myogenic cells are products of structural genes distinct from those coding for the myosins for skeletal myofibrils.

Lineages, quantal cell cycles, and the generation of cell diversity

Most theories of determination or differentiation assume that embryonic cells differ from mature cells. Embryonic cells are thought to have metastable control mechanisms. These labile controls are believed to become progressively more stabilized as the cells differentiate. Zygote, blastula, neural plate, limb bud, somite, or ‘stem’ cells are conceived of as undifferentiated, totipotent, or multipotential cells. As such, these cells supposedly have available for activation a larger repertoire of phenotypic programmes than their progeny. A necessary corollary to this view is that the activation of one particular phenotypic programme out of the many available is a function of instructive exogenous inducing molecules.

Thick and thin filaments in postmitotic, mononucleated myoblasts

Addition of cytochalasin B to primary muscle cultures allows the physical separation of postmitotic myogenic cells from replicating presumptive myoblasts and replicating fibroblasts. Mononucleated, postmitotic myoblasts proceed without fusion to synthesize myosin and actin and to assemble these proteins into thick and thin filaments. Although sarcomeres oriented in tandem are not evident and A, H, and I bands are atypical in these mononucleated myoblasts, the irregularly scattered clusters of myofilaments are assembled into remarkably normal interdigitating arrays. These scattered clusters of stacked thick and thin filaments permit the cell to contact spontaneously in the presence of cytochalasin B.

Effects of cytochaslasin B and colcemide on myogenic cultures

Muscle cultures treated with cytochalasin B yield mono- and oligonucleated cells of two kinds: (i) arborized, replicating precursor myogenic cells and fibroblasts; and (ii) round, post-mitotic, terminally differentiating myoblasts and myotubes. The arborized cells do not bind fluorescein-labeled antibody against myosin, do not contract rhythmically, and do not display hexagonally stacked thick and thin filaments. The round, mono-nucleated myoblasts and round, oligonucleated myotubes bind the fluorescein-labeled antibody against myosin, contract rhythmically, and display clusters of hexagonally-stacked thick and thin filaments. When cytochalasin B is removed and replaced by colcemide, the arborized cells, but not the post-mitotic muscle cells, acquire a radial symmetry and are induced to assemble massive, meandering cables that may occupy over 25% of the cell volume. These tortuous calbes are positively birefringent and consist exclusively of enormous numbers of 100-A, intermediate-sized filaments.